PR Newswire All News ReleasesQwen · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 06:30:00·⟳ 抓取 06:31:39 +1m39s·⚡ 决策 08-28 06:34:07 +2m28s·60.8 天前
Pomerantz律所宣布调查Teladoc Health投资者索赔，系7月底指引下调暴跌后的常规集体诉讼招募
Pomerantz的投资者警报是7月29日指引下调暴跌后的常规律所集体诉讼招募广告，不含任何关于Teladoc业务、财务或运营的新增事实。真正的催化事件（全年收入指引从$2.48B-$2.58B下调至$2.36B-$2.45B，股价单日-38.32%）已发生在近一个月前，市场已充分消化。律所调查公告不构成新的交易催化，无方向性edge。
📄 原文PR Newswire All News Releases↗ 原文
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health,…
不做 Teladoc Health（TDOC.US）
本次事件是律所集体诉讼招募广告（Attorney advertising），不含任何关于Teladoc的新增事实。真正的催化（全年收入指引下调$2.48B-$2.58B→$2.36B-$2.45B，股价-38.32%）发生在近一个月前的7月29-30日，已被市场充分消化。无增量信息、无方向性edge、无可交易催化。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Pomerantz LLP于8月27日发布投资者警报，宣布调查Teladoc是否存在证券欺诈。该公告引用的唯一事实是7月29日Teladoc下调全年收入指引并导致次日股价暴跌38.32%——这一事件已过去近一个月。律所调查公告是暴跌后的标准程序性动作（招募集体诉讼原告），不披露任何新的公司级信息，不改变对Teladoc基本面或股价的预期。无增量事实、无方向性edge，判定不做。
🔎 新鲜度:最早出现 2026-08-27 · 扩散 low · price-in 风险 high ↗
消息传播链
- 2026-07-29首发Teladoc Health Q2 2026财报Teladoc发布Q2财报并下调全年收入指引至$2.36B-$2.45B，这是本次律所调查所依据的原始事件市场反应:7月30日TDOC下跌$2.60（-38.32%）至$6.58
- 律所发布投资者警报招募集体诉讼原告，引用7月29日指引下调为唯一事实依据；不含任何新增公司级信息
反向证据
- 做空前查反向 · 来源 web · 日期 2026-08-27 · 影响 none
未发现8月份有任何关于Teladoc的新增负面事实；本次律所公告引用的唯一事件仍是7月29日的指引下调
检索:Teladoc TDOC new negative news August 2026
先例如何影响了这次决策
对本次决策的影响:无需先例校准，因为事件本身不含可交易的增量信息
方向:不适用——本事件为律所程序性公告，无方向性交易含义
涨幅量级:不适用
形态:不适用
工具执行结果 · 成功 4 · 降级 0 · 失败 0 · 取消 0
- fetch_decision_experience 成功 stock_tools HTTP · 67 ms
{ - search_processed_events 成功 stock_tools HTTP · 892 ms
{"result": "search_processed_events:agent query=`pomerantz teladoc investor alert | teladoc guidance cut q2 2026 | teladoc health tdoc securities fraud investigation`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 66.6/72 小时、11518 条本臂决策(完整)，返回 1 条候选。\n• 08-27 12:27 UTC(CST 20:27) [ticker] 不做 ISRG.US,TDOC.US (news_center) - search_case_library 成功 stock_tools HTTP · 62 ms
{"result": "search_case_library「TDOC.US」—— 与这些标的相关的自家决策案例(本页 5 条,该标的全历史相关记录共 19 条；ENTER 只按该标的自己的腿统计):\n◆ TDOC.US：相关历史决策 19 条 · 其中该标的 ENTER 2 条(10.5%) · 已结算 2 笔 · 胜率 0% · 中位 -0.81% · 均值 -0.81% ⚠️只有 2 笔,样本太薄,只能当线索不能当规律\n↑ 胜率/收益口径:ENTER 当日之后 T+1 开盘入场、次日开盘出场,做空腿已按方向取反(所以正数=这个方向做对了)。统计的只有★那只票自己的腿。\n【对所查标 - web_search 成功 Bing RSS(Tavily 降级后备) · 612 ms
web_search「Teladoc Health TDOC stock news August 2026」命中 5 条(Bing RSS 后备；Tavily: HTTP 432 {"detail":{"error":"This request exceeds your plan's set usage limit. Please upgrade your plan or contact support@tavily.com"}})：
原文全文
展开原文 · 1,973 字
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Teladoc and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 29, 2026, Teladoc reported its financial results for the second quarter of 2026 and updated its full-year 2026 revenue guidance to a range of $2.36 billion to $2.45 billion, compared to prior guidance in the range of $2.48 billion to $2.58 billion. Teladoc cited "uncertainties inherent in cash pay and ongoing business model transition". The Company also identified various pressures facing its BetterHelp platform, including faster insurance preference, accelerated cash pay decline, and network capacity lagging demand.
On this news, Teladoc's stock price fell $2.60 per share, or 38.32%, to close at $6.58 per share on July 30, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
The investigation concerns whether Teladoc and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 29, 2026, Teladoc reported its financial results for the second quarter of 2026 and updated its full-year 2026 revenue guidance to a range of $2.36 billion to $2.45 billion, compared to prior guidance in the range of $2.48 billion to $2.58 billion. Teladoc cited "uncertainties inherent in cash pay and ongoing business model transition". The Company also identified various pressures facing its BetterHelp platform, including faster insurance preference, accelerated cash pay decline, and network capacity lagging demand.
On this news, Teladoc's stock price fell $2.60 per share, or 38.32%, to close at $6.58 per share on July 30, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。